左予備スペース
回光返照 SEA Research, BLK 758 Yishun Street 72 #09-444 Singapore 760758
Let's turn the light inwards, illuminate the Self.
右予備スペース
About Us Your Comment
Site Search
Delivered from Singapore
SEAnews Issue:monthly
tel:65-87221054
対日関係 Relation with Japan in 2013
◄◄◄ back13件の関連記事が見つかりました( 1/1 pageを表示 [ 1~13 ] )next ►►►
元のページへ戻る ►2013-08-08 ArtNo.44549(1/13)
◆サントリー、Tilaknagar株購入協議
 世界第二の売れ筋ブランディー・ラベル『Mansion House』の製造元、Tilaknagar Industries Ltd(TIL:前社名The Maharashtra Sugar Mills Limited)は、サントリーホールディングスやフランスの酒造会社ペルノ・リカール( Pernod Ricard)に対して15~20%の自社株売却交渉を進めている。(...続きを読む)
◆Suntory, Pernod Ricard in talks to buy stake in Tilaknagar Industries
Tilaknagar Industries (TI), the maker of Mansion House, the world’s second-best-selling brandy label, is in talks with global giants like Suntory Holdings and Pernod Ricard to sell a 15-20 per cent stake in the company.
◆日法酒商谈判入股在Tilaknagar工业
  世界第二最畅销的白兰地标签万胜的制造商Tilaknagar工业有限公司正在与三得利控股公司和保乐力加(Pernod Ricard)等全球巨头谈判,出售15-20%的其股份。
2013-08-08 ArtNo.44550(2/13)
◆日法酒商谈判入股在Tilaknagar工业
  世界第二最畅销的白兰地标签万胜的制造商Tilaknagar工业有限公司正在与三得利控股公司和保乐力加(Pernod Ricard)等全球巨头谈判,出售15-20%的其股份。(...続きを読む)
◆Suntory, Pernod Ricard in talks to buy stake in Tilaknagar Industries
Tilaknagar Industries (TI), the maker of Mansion House, the world’s second-best-selling brandy label, is in talks with global giants like Suntory Holdings and Pernod Ricard to sell a 15-20 per cent stake in the company.
2013-08-08 ArtNo.44551(3/13)
◆Suntory, Pernod Ricard in talks to buy stake in Tilaknagar Industries
Tilaknagar Industries (TI), the maker of Mansion House, the world’s second-best-selling brandy label, is in talks with global giants like Suntory Holdings and Pernod Ricard to sell a 15-20 per cent stake in the company.(...続きを読む)
◆日法酒商谈判入股在Tilaknagar工业
  世界第二最畅销的白兰地标签万胜的制造商Tilaknagar工业有限公司正在与三得利控股公司和保乐力加(Pernod Ricard)等全球巨头谈判,出售15-20%的其股份。
2013-08-16 ArtNo.44582(4/13)
◆ヒーロー・モーター、100%国産車開発
【グルガオン】インド最大の二輪車製造会社Hero MotoCorp(HMC)は8日、今後数年内に100%国産の製品を発売すると発表した。(...続きを読む)
◆Hero MotoCorp to develop 100% made-in-India products
Gurgaon, Aug 8: The country’s largest two-wheeler manufacturer Hero MotoCorp on Thursday said that the company will launch products developed 100 per cent in India in the next few years.
◆英雄摩托车公司要推出100%国产摩托车
【古尔加翁】印度国内最大的两轮车制造商英雄摩托车公司8月8日表示,该公司未来几年内有意推出100%在印度国内发展和制造的产品。
2013-08-16 ArtNo.44585(5/13)
◆ヒーロー、50新市場に注目、売り上げ6万クロー目指す
 国内最大の二輪車メーカー、Hero MotoCorpは8日、2020年までに50新市場に進出し、全世界に20製造拠点を展開、年商6万クローを実現する目標を明らかにした。(...続きを読む)
◆Hero eyes 50 new markets, Rs 60,000-cr turnover by 2020
Country' largest two-wheeler maker Hero MotoCorp today said it plans to enter 50 new markets by 2020 with a target of 20 manufacturing facilities across the globe and an overall annual turnover of Rs 60,000 crore.
◆英雄摩托车到2020年底前开拓50个新市场,营业额6万cr卢比
  印度国内最大的两轮车制造商英雄摩托车公司计划到2020年底前开拓50个新市场,在全世界设20个制造基地,从而实现一年营业额6万cr卢比。
2013-08-16 ArtNo.44583(6/13)
◆英雄摩托车公司要推出100%国产摩托车
【古尔加翁】印度国内最大的两轮车制造商英雄摩托车公司8月8日表示,该公司未来几年内有意推出100%在印度国内发展和制造的产品。(...続きを読む)
◆Hero MotoCorp to develop 100% made-in-India products
Gurgaon, Aug 8: The country’s largest two-wheeler manufacturer Hero MotoCorp on Thursday said that the company will launch products developed 100 per cent in India in the next few years.
2013-08-16 ArtNo.44586(7/13)
◆英雄摩托车到2020年底前开拓50个新市场,营业额6万cr卢比
  印度国内最大的两轮车制造商英雄摩托车公司计划到2020年底前开拓50个新市场,在全世界设20个制造基地,从而实现一年营业额6万cr卢比。(...続きを読む)
◆Hero eyes 50 new markets, Rs 60,000-cr turnover by 2020
Country' largest two-wheeler maker Hero MotoCorp today said it plans to enter 50 new markets by 2020 with a target of 20 manufacturing facilities across the globe and an overall annual turnover of Rs 60,000 crore.
2013-08-16 ArtNo.44584(8/13)
◆Hero MotoCorp to develop 100% made-in-India products
Gurgaon, Aug 8: The country’s largest two-wheeler manufacturer Hero MotoCorp on Thursday said that the company will launch products developed 100 per cent in India in the next few years. (...続きを読む)
◆英雄摩托车公司要推出100%国产摩托车
【古尔加翁】印度国内最大的两轮车制造商英雄摩托车公司8月8日表示,该公司未来几年内有意推出100%在印度国内发展和制造的产品。
2013-08-16 ArtNo.44587(9/13)
◆Hero eyes 50 new markets, Rs 60,000-cr turnover by 2020
Country' largest two-wheeler maker Hero MotoCorp today said it plans to enter 50 new markets by 2020 with a target of 20 manufacturing facilities across the globe and an overall annual turnover of Rs 60,000 crore.(...続きを読む)
◆英雄摩托车到2020年底前开拓50个新市场,营业额6万cr卢比
  印度国内最大的两轮车制造商英雄摩托车公司计划到2020年底前开拓50个新市场,在全世界设20个制造基地,从而实现一年营业额6万cr卢比。
2013-12-20 ArtNo.44668(10/13)
◆Special sale for Restarting delivery:Free of charge until the end of September, 2014
【Sponsored Story】With the resumption of SEAnews' delivery, we will carry out special sales for banner ad spaces. If you sign up for three months' advertising from October 1, 2014, you may advertise on our newsletters and websites free of charge until the end of September, 2014(except for the Sponsored Stories). You may monitor the effectiveness of the advertisements during this period, and apply for a cancellation and a full 3 months refund by the end of August, 2014 if you feel that the advertisements are ineffective.
○Free of charge until the end of September, 2014
○Free for WEB Text Ad in 3 months from the 1st Octoberl 2014
○Free for WEB Picture Ad in 3 months from the 1st October 2014(...続きを読む)
2013-12-24 ArtNo.44681(11/13)
◆第一、ランバクシーの米国FDA規則クリア支援
【ニューデリー】第一三共株式会社は、Ranbaxy Laboratories Ltd(RLL)が米国食品薬品局(FDA:Food and Drug Administration)の規則を満たし、禁輸解除を支援する方針を明らかにした。(...続きを読む)
2013-12-24 ArtNo.44682(12/13)
◆日本制药商第一帮助兰伯西符合美国FDA标准
【新德里】日本制药商第一三共公司已经表示,它将帮助兰伯西实验室有限公司符合美国美国食品药品管理局(FDA)的标准并脱离FDA制裁。(...続きを読む)
2013-12-24 ArtNo.44683(13/13)
◆Daiichi to help Ranbaxy meet US FDA norms
【New Delhi】Japanese drug-maker Daiichi Sankyo has said it will help Ranbaxy Laboratories Ltd meet the US Food and Drug Administration's (FDA) norms to overcome sanctions.(...続きを読む)
右ペイン・広告スペース
[Your Comments / Unsubscribe]/[您的意见/退订]/[ご意見/配信停止]
Please do not directly reply to the e-mail address which is used for delivering the newsletter.
请别用递送新闻的邮件地址而直接回信。
メールをお届けした送信専用アドレスには返信しないで下さい。
SEAnews 掲載記事の無断転載を禁じます。すべての内容は日本の著作権法並びに国際条約により保護されています。
Copyright 2003 SEAnews® All rights reserved. No reproduction or republication without written permission.